Biodesix, Inc. (BDSX) vs Eupraxia Pharmaceuticals Inc. (EPRX)
A side-by-side comparison of Biodesix, Inc. and Eupraxia Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDSX
Biodesix, Inc.
$28.29HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
EPRX
Eupraxia Pharmaceuticals Inc.
$7.96HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
Total return — BDSX vs EPRX
growth of $100 · dividends reinvested · last 2yBDSX -3.8% (-1.9%/yr)EPRX +162.7% (+62.1%/yr)EPRX compounded faster over this window
BDSX EPRX
BDSX vs EPRX: by the numbers
- •EPRX is the larger company ($267M vs $230M market cap).
- •Both run net losses; EPRX's is the smaller (0.00% vs -26.97% net margin).
Metrics side by side
Valuation
| Metric | BDSX | EPRX |
|---|---|---|
| P/S ratio | 2.24 | N/A |
| P/B ratio | 25.18 | 2.62 |
Profitability
| Metric | BDSX | EPRX |
|---|---|---|
| Gross margin | 82.50% | 0.00% |
| Operating margin | -31.37% | 0.00% |
| Net margin | -26.97% | 0.00% |
| ROE | -303.61% | -38.33% |
| ROIC | -25.73% | -43.56% |
Growth (annualized)
| Metric | BDSX | EPRX |
|---|---|---|
| Revenue CAGR (5Y) | 5.99% | N/A |
| Total return CAGR (5Y) | -28.49% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.